Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![AnnaLsaac54 Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1652160179205537792.png) Anna Isaac [@AnnaLsaac54](/creator/twitter/AnnaLsaac54) on x 4835 followers
Created: 2025-07-23 10:31:23 UTC

$ABVX
Abivax Announces Positive Phase X Results From Both ABTECT 8-Week Induction Trials Investigating Obefazimod, Its First-in-Class Oral MiR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis
Click to get the full 🚀🚀🚀

![](https://pbs.twimg.com/media/GwiSXLPbYAAHUmZ.png)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947967775227760865/c:line.svg)

**Related Topics**
[$abvx](/topic/$abvx)

[Post Link](https://x.com/AnnaLsaac54/status/1947967775227760865)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

AnnaLsaac54 Avatar Anna Isaac @AnnaLsaac54 on x 4835 followers Created: 2025-07-23 10:31:23 UTC

$ABVX Abivax Announces Positive Phase X Results From Both ABTECT 8-Week Induction Trials Investigating Obefazimod, Its First-in-Class Oral MiR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis Click to get the full 🚀🚀🚀

XXX engagements

Engagements Line Chart

Related Topics $abvx

Post Link

post/tweet::1947967775227760865
/post/tweet::1947967775227760865